{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:24:23Z","timestamp":1793337863561,"version":"4.5.0"},"reference-count":54,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Polycystic ovary syndrome (PCOS) is a common endocrine disorder, characterized by subfertility, increased risk of metabolic diseases, and pregnancy complications. Previous studies diverge regarding the association between maternal PCOS and newborn anthropometrics.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To explore the association between maternal PCOS and newborn anthropometrics and the modifying effects of maternal body mass index, PCOS phenotype, and gestational diabetes.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study followed up women from the first half of pregnancy to birth and combined data from 3 clinical trials of pregnant women with PCOS and a reference population consisting of participants in the Norwegian Mother, Father, and Child Cohort (MoBa) Study, with data from the Medical Birth Registry of Norway. The recruitment period for the clinical trials was between October 1, 2000, and August 31, 2017, and for MoBa, between July 1, 1999, and December 31, 2008. Participants included women with singleton pregnancies and live-born children. Data were analyzed from January 1 to June 15, 2023.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Maternal PCOS status.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n Newborn birth weight, birth length, and head circumference as continuous variables and\n z<\/jats:italic>\n scores, and ponderal index (calculated as the birth weight in grams \u00d7 100 divided by the birth length in centimeters cubed), placenta weight, and ratio of birth weight to placenta weight (BWPW).\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The cohort included 390 pregnant women with PCOS (mean [SD] age, 29.6 [4.2] years) and 68 708 women in the reference group (mean [SD] age, 30.4 [4.5] years). Offspring in the PCOS group had lower birth weight, birth length, and head circumference than in the reference group offspring. The estimated mean differences in\n z<\/jats:italic>\n scores were \u22120.26 (95% CI, \u22120.38 to \u22120.14) for birth weight, \u22120.19 (95% CI, \u22120.33 to \u22120.05) for birth length, and \u22120.13 (95% CI, \u22120.26 to \u22120.01) for head circumference. The PCOS group also had a lower ponderal index (\u22120.04 [95% CI, \u22120.07 to \u22120.004] g \u00d7 100\/cm\n 3<\/jats:sup>\n ). The association between growth restriction and PCOS was more apparent when additionally adjusting for body mass index. Neither PCOS phenotype nor gestational diabetes diagnosis was associated with neonatal anthropometry in women with PCOS.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort of mother-infant pairs, maternal PCOS status was associated with lower birth weight, shorter birth length, and smaller head circumference in the offspring. This growth restriction was more pronounced when adjusting for BMI, providing insight into the association between PCOS and body mass index. The study contributed to the understanding of how PCOS affects the offspring.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.30543","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T11:01:15Z","timestamp":1724756475000},"page":"e2430543","source":"Crossref","is-referenced-by-count":29,"title":["Growth Restriction in the Offspring of Mothers With Polycystic Ovary Syndrome"],"prefix":"10.1001","volume":"7","author":[{"given":"Maren Sophie Aaserud","family":"Talmo","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild Skogedal","family":"Fl\u00f8ysand","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guro \u00d8rndal","family":"Nilsen","sequence":"additional","affiliation":[{"name":"St Olavs Hospital, University Hospital of Trondheim, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone S.","family":"L\u00f8vvik","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway"},{"name":"Department of Obstetrics and Gynecology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f8nnaug","family":"\u00d8deg\u00e5rd","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway"},{"name":"Centre for Obesity Research, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petur Benedikt","family":"Juliusson","sequence":"additional","affiliation":[{"name":"Department of Health Registry Research and Development, National Institute of Public Health, Bergen, Norway"},{"name":"Department of Clinical Science, University of Bergen, Bergen, Norway"},{"name":"Department of Paediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Vanky","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway"},{"name":"Department of Obstetrics and Gynecology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie Rae","family":"Simpson","sequence":"additional","affiliation":[{"name":"Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"issue":"4","key":"zoi240922r1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review.","volume":"13","author":"Deswal","year":"2020","journal-title":"J Hum Reprod Sci"},{"issue":"10","key":"zoi240922r2","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"zoi240922r3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome.","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"issue":"6","key":"zoi240922r4","doi-asserted-by":"publisher","first-page":"558.e1","DOI":"10.1016\/j.ajog.2011.03.021","article-title":"Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis.","volume":"204","author":"Kjerulff","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"zoi240922r5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome.","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"1","key":"zoi240922r6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1210\/clinem\/dgab684","article-title":"Changes in serum cytokines throughout pregnancy in women with polycystic ovary syndrome.","volume":"107","author":"Stokkeland","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"zoi240922r7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s13224-020-01356-y","article-title":"Pregnancy outcome in women with polycystic ovary syndrome.","volume":"70","author":"Mann","year":"2020","journal-title":"J Obstet Gynaecol India"},{"issue":"1","key":"zoi240922r8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12958-022-00905-6","article-title":"Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study.","volume":"20","author":"Fornes","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"zoi240922r9","first-page":"207","article-title":"Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls.","volume":"17","author":"Mehrabian","year":"2012","journal-title":"J Res Med Sci"},{"issue":"2","key":"zoi240922r10","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1210\/jc.2017-01191","article-title":"Fetal growth and birth anthropometrics in metformin-exposed offspring born to mothers with PCOS.","volume":"103","author":"Hjorth-Hansen","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"zoi240922r11","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1210\/jc.2017-02764","article-title":"Gestational weight gain in women with polycystic ovary syndrome: a controlled study.","volume":"103","author":"Kent","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"zoi240922r12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.fertnstert.2017.12.023","article-title":"Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.","volume":"109","author":"Li","year":"2018","journal-title":"Fertil Steril"},{"issue":"3","key":"zoi240922r13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1210\/jc.2018-01787","article-title":"Pre-conception characteristics predict obstetrical and neonatal outcomes in women with polycystic ovary syndrome.","volume":"104","author":"Christ","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"zoi240922r14","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/humrep\/deaa144","article-title":"Associations between polycystic ovary syndrome and adverse obstetric and neonatal outcomes: a population study of 9.1 million births.","volume":"35","author":"Mills","year":"2020","journal-title":"Hum Reprod"},{"issue":"10","key":"zoi240922r15","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.29271\/jcpsp.2021.10.1186","article-title":"Development of 1-2 years offspring born to mothers with polycystic ovary syndrome.","volume":"31","author":"Wang","year":"2021","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"zoi240922r16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12916-022-02473-3","article-title":"Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England.","volume":"20","author":"Subramanian","year":"2022","journal-title":"BMC Med"},{"issue":"11","key":"zoi240922r17","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/humrep\/deac210","article-title":"Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts.","volume":"37","author":"Farland","year":"2022","journal-title":"Hum Reprod"},{"issue":"11","key":"zoi240922r18","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/aogs.13200","article-title":"Insulin resistance in pregnant women with and without polycystic ovary syndrome, and measures of body composition in offspring at birth and three years of age.","volume":"96","author":"Finnbogad\u00f3ttir","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"zoi240922r20","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/humrep\/deh347","article-title":"Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.","volume":"19","author":"Vanky","year":"2004","journal-title":"Hum Reprod"},{"issue":"12","key":"zoi240922r21","doi-asserted-by":"publisher","first-page":"E448","DOI":"10.1210\/jc.2010-0853","article-title":"Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study.","volume":"95","author":"Vanky","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"zoi240922r22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","article-title":"Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.","volume":"7","author":"L\u00f8vvik","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"zoi240922r23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum Reprod"},{"issue":"2","key":"zoi240922r24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/ije\/dyw029","article-title":"Cohort profile update: the Norwegian Mother and Child Cohort Study (MoBa).","volume":"45","author":"Magnus","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"5","key":"zoi240922r25","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/ije\/dyl170","article-title":"Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa).","volume":"35","author":"Magnus","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"6","key":"zoi240922r26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1034\/j.1600-0412.2000.079006435.x","article-title":"The Medical Birth Registry of Norway: epidemiological research and surveillance throughout 30 years.","volume":"79","author":"Irgens","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"zoi240922r27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2431-8-8","article-title":"Continuous growth reference from 24th week of gestation to 24 months by gender.","volume":"8","author":"Niklasson","year":"2008","journal-title":"BMC Pediatr"},{"issue":"6","key":"zoi240922r30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/obr.12832","article-title":"The role of maternal obesity in infant outcomes in polycystic ovary syndrome\u2014a systematic review, meta-analysis, and meta-regression.","volume":"20","author":"Bahri Khomami","year":"2019","journal-title":"Obes Rev"},{"issue":"10","key":"zoi240922r31","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/aje\/kwn233","article-title":"What is spared by fetal brain-sparing? fetal circulatory redistribution and behavioral problems in the general population.","volume":"168","author":"Roza","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"10","key":"zoi240922r32","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/j.1471-0528.2004.00273.x","article-title":"Fetal responses to placental insufficiency: an update.","volume":"111","author":"Baschat","year":"2004","journal-title":"BJOG"},{"issue":"5","key":"zoi240922r33","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives.","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil Steril"},{"issue":"1","key":"zoi240922r34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"zoi240922r35","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s40618-020-01385-4","article-title":"Sex-dependent associations of maternal androgen levels with offspring BMI and weight trajectory from birth to early childhood.","volume":"44","author":"Huang","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"zoi240922r36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.fertnstert.2017.06.015","article-title":"Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotype.","volume":"108","author":"de Wilde","year":"2017","journal-title":"Fertil Steril"},{"issue":"5","key":"zoi240922r37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/1471-0528.12558","article-title":"Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia.","volume":"121","author":"Naver","year":"2014","journal-title":"BJOG"},{"issue":"2","key":"zoi240922r38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/aogs.12545","article-title":"Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.","volume":"94","author":"Mumm","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"zoi240922r39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.18502\/ijrm.v13i5.7154","article-title":"Maternal and neonatal outcomes among pregnant women with different polycystic ovary syndrome phenotypes: a cross-sectional study.","volume":"18","author":"Dehghani Firoozabadi","year":"2020","journal-title":"Int J Reprod Biomed"},{"issue":"1","key":"zoi240922r40","first-page":"18","article-title":"Effect of hyperandrogenism on obstetric complications of singleton pregnancy from in vitro fertilization in women with polycystic ovary syndrome.","volume":"53","author":"Wei","year":"2018","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"2","key":"zoi240922r41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1530\/REP-14-0055","article-title":"Developmental programing: impact of testosterone on placental differentiation.","volume":"148","author":"Beckett","year":"2014","journal-title":"Reproduction"},{"issue":"11","key":"zoi240922r42","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1096\/fj.202001060R","article-title":"Excess of ovarian nerve growth factor impairs embryonic development and causes reproductive and metabolic dysfunction in adult female mice.","volume":"34","author":"Manti","year":"2020","journal-title":"FASEB J"},{"key":"zoi240922r43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fphys.2016.00028","article-title":"Placental adaptation: what can we learn from birthweight:placental weight ratio?","volume":"7","author":"Hayward","year":"2016","journal-title":"Front Physiol"},{"issue":"6809","key":"zoi240922r44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/bmj.303.6809.1019","article-title":"Fetal and infant growth and impaired glucose tolerance at age 64.","volume":"303","author":"Hales","year":"1991","journal-title":"BMJ"},{"issue":"7153","key":"zoi240922r45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/bmj.317.7153.241","article-title":"Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15 000 Swedish men and women born 1915-29.","volume":"317","author":"Leon","year":"1998","journal-title":"BMJ"},{"issue":"3","key":"zoi240922r46","doi-asserted-by":"publisher","first-page":"176","DOI":"10.7326\/0003-4819-133-3-200008010-00008","article-title":"The fetal and childhood growth of persons who develop type 2 diabetes.","volume":"133","author":"Fors\u00e9n","year":"2000","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi240922r47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/GCO.0000000000000364","article-title":"Long-term consequences of obesity on female fertility and the health of the offspring.","volume":"29","author":"Chandrasekaran","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"zoi240922r48","doi-asserted-by":"publisher","first-page":"20865","DOI":"10.1038\/s41598-021-99869-7","article-title":"The associations between maternal BMI and gestational weight gain and health outcomes in offspring at age 1 and 7 years.","volume":"11","author":"Chiavaroli","year":"2021","journal-title":"Sci Rep"},{"issue":"8","key":"zoi240922r49","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s00125-019-4891-4","article-title":"Consequences of being overweight or obese during pregnancy on diabetes in the offspring: a record linkage study in Aberdeen, Scotland.","volume":"62","author":"Lahti-Pulkkinen","year":"2019","journal-title":"Diabetologia"},{"issue":"1","key":"zoi240922r50","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.50579","article-title":"Maternal diabetes and overweight and congenital heart defects in offspring.","volume":"7","author":"Turunen","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi240922r51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12887-020-1960-2","article-title":"Cognitive function in metformin exposed children, born to mothers with PCOS\u2014follow-up of an RCT.","volume":"20","author":"Greger","year":"2020","journal-title":"BMC Pediatr"},{"issue":"3","key":"zoi240922r52","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10803-022-05446-w","article-title":"Prenatal androgen exposure and traits of autism spectrum disorder in the offspring: Odense Child Cohort.","volume":"53","author":"Palm","year":"2023","journal-title":"J Autism Dev Disord"},{"issue":"4","key":"zoi240922r53","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1017\/S0033291719000424","article-title":"Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: prenatal androgen exposure or genetic confounding?","volume":"50","author":"Cesta","year":"2020","journal-title":"Psychol Med"},{"issue":"12","key":"zoi240922r54","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/s41380-019-0398-0","article-title":"Maternal polycystic ovarian syndrome in autism spectrum disorder: a systematic review and meta-analysis.","volume":"24","author":"Katsigianni","year":"2019","journal-title":"Mol Psychiatry"},{"key":"zoi240922r19","unstructured":"Teede? H, Tay? CT, Laven? JSE, . International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2023. Monash University. Updated February 2023. Accessed April 2, 2024. https:\/\/www.monash.edu\/__data\/assets\/pdf_file\/0003\/3379521\/Evidence-Based-Guidelines-2023.pdf"},{"key":"zoi240922r28","unstructured":"World Health Organization. Physical status: the use and interpretation of anthropometry: report of a WHO expert committee. February 28, 1995. Accessed March 26, 2024. https:\/\/iris.who.int\/handle\/10665\/37003"},{"key":"zoi240922r29","unstructured":"Helsedirektoratet. Gestational diabetes: national professional guideline. Updated June 6, 2023. Accessed March 26, 2024. https:\/\/www.helsedirektoratet.no\/retningslinjer\/svangerskapsdiabetes"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2822864\/talmo_2024_oi_240922_1772557461.18443.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:31:13Z","timestamp":1772559073000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2822864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.30543","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]}}}